Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy

Conditions:   Breast Cancer;   Hyperinsulinism;   HER2-negative Breast Cancer Intervention:   Drug: Dapagliflozin 10mg Sponsors:   Yale University;   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials